Perioperative durvalumab improved upon neoadjuvant chemotherapy in patients with cisplatin-eligible MIBC in the NIAGARA trial.

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application ...

Based on work Dr. Petrylak presented at ASCO 2024 looking at dose adjustment and efficacy of enfortumab vedotin, most ...

In this video, Aruna Padmanabhan, MD, discusses the management of side effects seen in patients receiving PI3K inhibitors for ...

We do know that unfortunately drugs that like, Voranigo that are IDH inhibitors alone are not enough in the grade 3 or 4 patients. So, we still need to talk about surgery, radiation, chemotherapy ...

RIT graduate student Bryona Hamilton is creating an educational guide for cancer survivors about chemotherapy side effects ...

His specialty is antibiotic-associated diarrhea. Guenter J Krejs is a Full Professor of Medicine and Chairman of the Department of Internal Medicine and Gastroenterology at Graz University Medical ...

Colorectal cancer is increasingly affecting younger adults, with symptoms often mistaken for minor digestive issues. Early screening, self-advocacy, and second opinions are crucial for timely ...

The pCR was 37.3% (95% CI, 33.2-41.6) in the durvalumab arm and 27.5% (95% CI, 23.8-31.6) in the comparator arm.

Operations Safe Neighborhood was formed three years ago with the goal of getting guns off the streets and out of the hands of criminals. A symphony of snowblowers and shovels were across mid ...

Clinical trials have studied the effects and safety of resveratrol doses of up to 3 grams daily. Trials have reported that ... that people experience gastrointestinal side effects such as diarrhea and ...